Filing Details

Accession Number:
0001610717-23-000278
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-12 17:24:25
Reporting Period:
2023-09-08
Accepted Time:
2023-09-12 17:24:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611311 P. David Rosenbaum C/O Ardelyx, Inc.
34175 Ardenwood Blvd, Suite 100
Fremont CA 94555
Chief Development Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-09-08 2,897 $4.55 367,022 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 114,225 Indirect By Wife
Common Stock 77,592 Indirect Family Trust
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023.
  2. Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2023.
  3. The shares are directly held by the Reporting Person's wife.
  4. The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.